Synovial Immunopathology in Psoriatic Arthritis: Cellular and Molecular Insights

Ryan Hum*, Maria Christofi, Samantha Smith, Lysette Marshall, Darren Plant, Sebastien Viatte, Pauline Ho, Paul Martin, Anne Barton

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Although psoriatic arthritis and rheumatoid arthritis are both common types of inflammatory arthritis characterised by synovial inflammation, studies have shown distinct molecular and cellular landscapes between these conditions. Recent advances in synovial research in psoriatic arthritis have begun to unlock important insights into disease pathogenesis and potential clinical applications. For example, studies using high-dimensional technologies have identified psoriatic arthritis specific macrophage, fibroblast, and mast cell subsets, as well as specific cytokines such as IL-36 and IL-41. This review explores how research of the synovium has advanced our understanding of psoriatic arthritis, the potential of identified cell types and cytokines as biomarkers and novel therapeutic targets, how limited sample sizes in high-dimensional studies are hindering clinical translation, and the future directions for synovial research in psoriatic arthritis. 
Original languageEnglish
JournalThe Lancet Rheumatology
Publication statusAccepted/In press - 6 Aug 2025

Fingerprint

Dive into the research topics of 'Synovial Immunopathology in Psoriatic Arthritis: Cellular and Molecular Insights'. Together they form a unique fingerprint.

Cite this